These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 14746627

  • 1. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.
    Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis.
    Daudén E, Pedraz J, Alvarez-Ruiz S, García-Río I, Sánchez-Peinado C, Oñate MJ, García-Diez A.
    Eur J Dermatol; 2010 Jan; 20(3):321-2. PubMed ID: 20146966
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
    Geilen CC, Arnold M, Orfanos CE.
    Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
    [Abstract] [Full Text] [Related]

  • 4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M, Chams-Davatchi C, Hemami MR, Fateh S.
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [Abstract] [Full Text] [Related]

  • 6. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [Abstract] [Full Text] [Related]

  • 7. Monitoring trough plasma concentrations of mycophenolate mofetil in patients with uveitis.
    Llinares-Tello F, Hernández-Prats C, Muñoz-Ruiz C, Selva-Otaolaurruchi J, Ordovás-Baines JP.
    J Clin Pharm Ther; 2004 Feb; 29(1):53-8. PubMed ID: 14748898
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
    Kaplan B.
    Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
    [Abstract] [Full Text] [Related]

  • 9. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.
    Parant F, Rivet C, Boulieu R, Gagnieu MC, Dumortier J, Boillot O, Lachaux A.
    Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404
    [Abstract] [Full Text] [Related]

  • 10. Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil.
    Neumann I, Fuhrmann H, Fang IF, Jaeger A, Bayer P, Kovarik J.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3514-20. PubMed ID: 18586766
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
    Pape L, Ehrich JH, Offner G.
    Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
    [Abstract] [Full Text] [Related]

  • 12. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
    Merkel U, Lindner S, Vollandt R, Sperschneider H, Balogh A.
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
    [Abstract] [Full Text] [Related]

  • 13. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA.
    Dermatology; 2009 Aug; 219(2):126-32. PubMed ID: 19546522
    [Abstract] [Full Text] [Related]

  • 14. Relationship between mycophenolate mofetil side effects and mycophenolic acid plasma trough levels in renal transplant patients.
    Hubner GI, Eismann R, Sziegoleit W.
    Arzneimittelforschung; 2000 Oct; 50(10):936-40. PubMed ID: 11105237
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
    Zhou Y, Rosenthal D, Dutz J, Ho V.
    J Cutan Med Surg; 2003 Oct; 7(3):193-7. PubMed ID: 12704533
    [Abstract] [Full Text] [Related]

  • 16. What is the intrapatient variability of mycophenolic acid trough levels?
    Todorova EK, Huang SH, Kobrzynski MC, Filler G.
    Pediatr Transplant; 2015 Nov; 19(7):669-74. PubMed ID: 26201386
    [Abstract] [Full Text] [Related]

  • 17. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
    Tredger JM, Brown NW, Adams J, Gonde CE, Dhawan A, Rela M, Heaton N.
    Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791
    [Abstract] [Full Text] [Related]

  • 18. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
    Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA.
    Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis.
    Kittanamongkolchai W, Rukrung C, Supasiri T, Lertjirachai I, Somparn P, Chariyavilaskul P, Avihingsanon Y.
    Lupus; 2013 Jun; 22(7):727-32. PubMed ID: 23651860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.